Rank | Gene Set | Z-score |
---|---|---|
1 | endocrine pancreas development (GO:0031018) | 7.98002323 |
2 | protein maturation by protein folding (GO:0022417) | 7.87185431 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.70574705 |
4 | COPII vesicle coating (GO:0048208) | 7.05770112 |
5 | peptide hormone processing (GO:0016486) | 6.96706212 |
6 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 6.86602091 |
7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.81056633 |
8 | protein retention in ER lumen (GO:0006621) | 6.72000753 |
9 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 6.33434562 |
10 | signal peptide processing (GO:0006465) | 6.28360157 |
11 | type B pancreatic cell development (GO:0003323) | 6.25648489 |
12 | glandular epithelial cell differentiation (GO:0002067) | 5.92337994 |
13 | exocrine pancreas development (GO:0031017) | 5.90985003 |
14 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.77947094 |
15 | glandular epithelial cell development (GO:0002068) | 5.73747821 |
16 | sequestering of metal ion (GO:0051238) | 5.59239857 |
17 | positive regulation of nuclease activity (GO:0032075) | 5.52560930 |
18 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.29902755 |
19 | positive regulation of insulin secretion (GO:0032024) | 5.24044474 |
20 | vesicle coating (GO:0006901) | 5.23073449 |
21 | insulin secretion (GO:0030073) | 5.22915558 |
22 | adenosine metabolic process (GO:0046085) | 5.18447863 |
23 | regulation of nuclease activity (GO:0032069) | 5.03870846 |
24 | regulation of plasminogen activation (GO:0010755) | 4.96401459 |
25 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.87625230 |
26 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.78612230 |
27 | cellular response to unfolded protein (GO:0034620) | 4.75766014 |
28 | ER overload response (GO:0006983) | 4.74395601 |
29 | * regulation of insulin secretion (GO:0050796) | 4.71409158 |
30 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.68124537 |
31 | cellular response to topologically incorrect protein (GO:0035967) | 4.67454119 |
32 | ER-nucleus signaling pathway (GO:0006984) | 4.58047277 |
33 | nitric oxide mediated signal transduction (GO:0007263) | 4.55582508 |
34 | regulation of endothelial cell differentiation (GO:0045601) | 4.54767577 |
35 | white fat cell differentiation (GO:0050872) | 4.53169693 |
36 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.50013228 |
37 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.49197290 |
38 | sulfur amino acid catabolic process (GO:0000098) | 4.39952676 |
39 | * regulation of peptide hormone secretion (GO:0090276) | 4.29998809 |
40 | negative regulation of norepinephrine secretion (GO:0010700) | 4.29078506 |
41 | positive regulation of peptide hormone secretion (GO:0090277) | 4.23916895 |
42 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.23259423 |
43 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.23259423 |
44 | * regulation of peptide secretion (GO:0002791) | 4.21843384 |
45 | thrombin receptor signaling pathway (GO:0070493) | 4.21345782 |
46 | negative regulation of catecholamine secretion (GO:0033604) | 4.14981359 |
47 | cellular response to vitamin D (GO:0071305) | 4.13633598 |
48 | intra-Golgi vesicle-mediated transport (GO:0006891) | 4.12587454 |
49 | positive regulation of peptide secretion (GO:0002793) | 4.09248228 |
50 | protein N-linked glycosylation via asparagine (GO:0018279) | 4.08128147 |
51 | peptidyl-asparagine modification (GO:0018196) | 4.05221421 |
52 | homocysteine metabolic process (GO:0050667) | 4.02369758 |
53 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.95214635 |
54 | response to endoplasmic reticulum stress (GO:0034976) | 3.91210199 |
55 | detection of calcium ion (GO:0005513) | 3.83577824 |
56 | peptide hormone secretion (GO:0030072) | 3.82053566 |
57 | microtubule nucleation (GO:0007020) | 3.80618585 |
58 | cellular zinc ion homeostasis (GO:0006882) | 3.80012201 |
59 | * regulation of hormone secretion (GO:0046883) | 3.74758997 |
60 | peptide secretion (GO:0002790) | 3.73835168 |
61 | protein N-linked glycosylation (GO:0006487) | 3.72505786 |
62 | regulation of gonadotropin secretion (GO:0032276) | 3.72004485 |
63 | cysteine metabolic process (GO:0006534) | 3.71900133 |
64 | response to unfolded protein (GO:0006986) | 3.67641592 |
65 | toxin metabolic process (GO:0009404) | 3.64836579 |
66 | protein localization to Golgi apparatus (GO:0034067) | 3.64499258 |
67 | positive regulation of glycolytic process (GO:0045821) | 3.63065288 |
68 | macroautophagy (GO:0016236) | 3.61614712 |
69 | response to topologically incorrect protein (GO:0035966) | 3.61225837 |
70 | organic cation transport (GO:0015695) | 3.56544177 |
71 | purine nucleotide salvage (GO:0032261) | 3.55200561 |
72 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.54878866 |
73 | regulation of sequestering of triglyceride (GO:0010889) | 3.53594946 |
74 | response to hexose (GO:0009746) | 3.52462375 |
75 | Golgi organization (GO:0007030) | 3.51587932 |
76 | regulation of hexokinase activity (GO:1903299) | 3.49901340 |
77 | regulation of glucokinase activity (GO:0033131) | 3.49901340 |
78 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48784091 |
79 | * regulation of peptide transport (GO:0090087) | 3.48097924 |
80 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.47676726 |
81 | response to glucose (GO:0009749) | 3.44549761 |
82 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.44381575 |
83 | endothelium development (GO:0003158) | 3.43290836 |
84 | positive regulation of hormone secretion (GO:0046887) | 3.40515715 |
85 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.37714309 |
86 | response to monosaccharide (GO:0034284) | 3.35817400 |
87 | negative regulation of bone resorption (GO:0045779) | 3.32318180 |
88 | astrocyte differentiation (GO:0048708) | 3.30581375 |
89 | * negative regulation of insulin secretion (GO:0046676) | 3.29989296 |
90 | platelet dense granule organization (GO:0060155) | 3.29255648 |
91 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.29065220 |
92 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.28782794 |
93 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.24461502 |
94 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.24172110 |
95 | nucleoside diphosphate catabolic process (GO:0009134) | 3.22013508 |
96 | epithelial cell fate commitment (GO:0072148) | 3.21717871 |
97 | cell migration involved in heart development (GO:0060973) | 3.20968711 |
98 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.20835226 |
99 | response to hepatocyte growth factor (GO:0035728) | 3.20305907 |
100 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.20305907 |
101 | tryptophan catabolic process (GO:0006569) | 3.17712163 |
102 | indole-containing compound catabolic process (GO:0042436) | 3.17712163 |
103 | indolalkylamine catabolic process (GO:0046218) | 3.17712163 |
104 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.17590230 |
105 | glucose homeostasis (GO:0042593) | 3.15416154 |
106 | carbohydrate homeostasis (GO:0033500) | 3.15416154 |
107 | regulation of glucocorticoid secretion (GO:2000849) | 3.12820030 |
108 | behavioral response to nicotine (GO:0035095) | 3.12139527 |
109 | Golgi vesicle transport (GO:0048193) | 3.09455987 |
110 | intestinal epithelial cell development (GO:0060576) | 3.06502813 |
111 | cellular response to glucagon stimulus (GO:0071377) | 3.05241184 |
112 | regulation of energy homeostasis (GO:2000505) | 3.02804564 |
113 | cartilage morphogenesis (GO:0060536) | 3.02375731 |
114 | 4-hydroxyproline metabolic process (GO:0019471) | 3.01765065 |
115 | tryptophan metabolic process (GO:0006568) | 3.01062479 |
116 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.00542258 |
117 | GDP-mannose metabolic process (GO:0019673) | 3.00281123 |
118 | peptide transport (GO:0015833) | 2.99820411 |
119 | hormone secretion (GO:0046879) | 2.99475466 |
120 | intestinal absorption (GO:0050892) | 2.98497884 |
121 | regulation of oxidative phosphorylation (GO:0002082) | 2.97148063 |
122 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.96560433 |
123 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.96560433 |
124 | desmosome organization (GO:0002934) | 2.95512265 |
125 | negative regulation of protein localization to cell surface (GO:2000009) | 2.94477275 |
126 | tonic smooth muscle contraction (GO:0014820) | 2.94035337 |
127 | regulation of lipoprotein metabolic process (GO:0050746) | 2.93209600 |
128 | response to carbohydrate (GO:0009743) | 2.92967781 |
129 | xenobiotic catabolic process (GO:0042178) | 2.91655942 |
130 | growth hormone secretion (GO:0030252) | 2.91304482 |
131 | maintenance of protein localization in organelle (GO:0072595) | 2.87825672 |
132 | cardiolipin metabolic process (GO:0032048) | 2.87449200 |
133 | regulation of female receptivity (GO:0045924) | 2.87345652 |
134 | protein targeting to Golgi (GO:0000042) | 2.86731639 |
135 | protein-chromophore linkage (GO:0018298) | 2.86690242 |
136 | inner ear receptor cell development (GO:0060119) | 2.86064652 |
137 | * negative regulation of peptide hormone secretion (GO:0090278) | 2.85009323 |
138 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.85000747 |
139 | cellular response to hexose stimulus (GO:0071331) | 2.84736180 |
140 | primary amino compound metabolic process (GO:1901160) | 2.83439888 |
141 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81286772 |
142 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.79637472 |
143 | adaptation of signaling pathway (GO:0023058) | 2.76610816 |
144 | indolalkylamine metabolic process (GO:0006586) | 2.74936616 |
145 | cochlea development (GO:0090102) | 2.74895475 |
146 | galactose metabolic process (GO:0006012) | 2.74414268 |
147 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.71174077 |
148 | aromatic amino acid family catabolic process (GO:0009074) | 2.66252416 |
149 | aggressive behavior (GO:0002118) | 2.65771208 |
150 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.63308249 |
151 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63170913 |
152 | amine catabolic process (GO:0009310) | 2.62153841 |
153 | cellular biogenic amine catabolic process (GO:0042402) | 2.62153841 |
154 | photoreceptor cell differentiation (GO:0046530) | 2.62059809 |
155 | eye photoreceptor cell differentiation (GO:0001754) | 2.62059809 |
156 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.60035771 |
157 | amino acid salvage (GO:0043102) | 2.58428346 |
158 | L-methionine salvage (GO:0071267) | 2.58428346 |
159 | L-methionine biosynthetic process (GO:0071265) | 2.58428346 |
160 | galactose catabolic process (GO:0019388) | 2.57165440 |
161 | blood coagulation, intrinsic pathway (GO:0007597) | 2.56489919 |
162 | positive regulation of muscle hypertrophy (GO:0014742) | 2.54318144 |
163 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.54318144 |
164 | positive regulation of digestive system process (GO:0060456) | 2.52870914 |
165 | negative regulation of platelet activation (GO:0010544) | 2.52645849 |
166 | acrosome assembly (GO:0001675) | 2.47404992 |
167 | one-carbon metabolic process (GO:0006730) | 2.44793438 |
168 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.44332159 |
169 | tachykinin receptor signaling pathway (GO:0007217) | 2.43451567 |
170 | positive regulation of fatty acid oxidation (GO:0046321) | 2.42683647 |
171 | kynurenine metabolic process (GO:0070189) | 2.42047478 |
172 | cellular ketone body metabolic process (GO:0046950) | 2.42046710 |
173 | benzene-containing compound metabolic process (GO:0042537) | 2.40628033 |
174 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.38802688 |
175 | relaxation of smooth muscle (GO:0044557) | 2.37418919 |
176 | sulfur amino acid biosynthetic process (GO:0000097) | 2.36425781 |
177 | negative regulation of catenin import into nucleus (GO:0035414) | 2.36315837 |
178 | innervation (GO:0060384) | 2.36287614 |
179 | mitochondrial RNA metabolic process (GO:0000959) | 2.34541685 |
180 | autophagic vacuole fusion (GO:0000046) | 2.34007568 |
181 | protein-cofactor linkage (GO:0018065) | 2.33797280 |
182 | negative regulation of cell cycle arrest (GO:0071157) | 2.33553750 |
183 | regulation of platelet aggregation (GO:0090330) | 2.33015867 |
184 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.31758504 |
185 | regulation of platelet activation (GO:0010543) | 2.31633629 |
186 | cellular response to BMP stimulus (GO:0071773) | 2.30990299 |
187 | response to BMP (GO:0071772) | 2.30990299 |
188 | endosome to melanosome transport (GO:0035646) | 2.29587754 |
189 | endosome to pigment granule transport (GO:0043485) | 2.29587754 |
190 | heme transport (GO:0015886) | 2.29448026 |
191 | artery smooth muscle contraction (GO:0014824) | 2.29044431 |
192 | indole-containing compound metabolic process (GO:0042430) | 2.27684591 |
193 | interkinetic nuclear migration (GO:0022027) | 2.27365416 |
194 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.27028865 |
195 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.26558041 |
196 | negative regulation of lipid storage (GO:0010888) | 2.26483630 |
197 | Golgi transport vesicle coating (GO:0048200) | 11.6406821 |
198 | COPI coating of Golgi vesicle (GO:0048205) | 11.6406821 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.37354556 |
2 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 4.60334821 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.23192615 |
4 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.91121791 |
5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.48485933 |
6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.74462319 |
7 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.46889781 |
8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.29059277 |
9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.23018731 |
10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.11618896 |
11 | * VDR_22108803_ChIP-Seq_LS180_Human | 2.02381191 |
12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.98207541 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95766709 |
14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94418847 |
15 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.89977857 |
16 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.85452589 |
17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83780917 |
18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81643334 |
19 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.79708987 |
20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77648589 |
21 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.77332470 |
22 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.76266615 |
23 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.76194315 |
24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.74216917 |
25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72191451 |
26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.71411719 |
27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67977189 |
28 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.66985618 |
29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64810640 |
30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63902917 |
31 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62883217 |
32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.58654480 |
33 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.54967752 |
34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54827091 |
35 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.52641732 |
36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.51409268 |
37 | AR_25329375_ChIP-Seq_VCAP_Human | 1.51309117 |
38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.50692736 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50212504 |
40 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.49198599 |
41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48556400 |
42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48543636 |
43 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.47787362 |
44 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.45373321 |
45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44948210 |
46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44921317 |
47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44847516 |
48 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42317083 |
49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.40194535 |
50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39438327 |
51 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37219311 |
52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36167299 |
53 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.35907909 |
54 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.35851257 |
55 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34868509 |
56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32530068 |
57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32530068 |
58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31622763 |
59 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.31351851 |
60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30943921 |
61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30921835 |
62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30531182 |
63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29627904 |
64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29255480 |
65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28913404 |
66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28721782 |
67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28105122 |
68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28105122 |
69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27674725 |
70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.27515213 |
71 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.26669410 |
72 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.25009326 |
73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24681748 |
74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23745913 |
75 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21684802 |
76 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21331676 |
77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21214687 |
78 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20973324 |
79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20682307 |
80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.20246958 |
81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19927293 |
82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18936124 |
83 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.18752153 |
84 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18252493 |
85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17060000 |
86 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15884951 |
87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15884951 |
88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15193704 |
89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15180144 |
90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14225367 |
91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14039723 |
92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12903618 |
93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12831110 |
94 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12243790 |
95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11896623 |
96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10840539 |
97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10459523 |
98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10142127 |
99 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09801128 |
100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09026726 |
101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08733456 |
102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08659699 |
103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08445541 |
104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08358894 |
105 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08053962 |
106 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07751051 |
107 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.07491027 |
108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07318896 |
109 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06949058 |
110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06503726 |
111 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.06235819 |
112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06135386 |
113 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06031346 |
114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05863272 |
115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05229232 |
116 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04803344 |
117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.04576093 |
118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04289480 |
119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03735022 |
120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03515391 |
121 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03462592 |
122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03251046 |
123 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03209959 |
124 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02562206 |
125 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02081496 |
126 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02037531 |
127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01986394 |
128 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01185043 |
129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00654274 |
130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00133731 |
131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99721308 |
132 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98132599 |
133 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96400962 |
134 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95867000 |
135 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95528260 |
136 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.94539764 |
137 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94463425 |
138 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93786593 |
139 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91592152 |
140 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86559733 |
141 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.85960345 |
142 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84642571 |
143 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.84530209 |
144 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.84497733 |
145 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.83445638 |
146 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82882069 |
147 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82882069 |
148 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82791019 |
149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82183376 |
150 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82103346 |
151 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81748172 |
152 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.80878076 |
153 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80580062 |
154 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.80548972 |
155 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80015808 |
156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.79821656 |
157 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.79565678 |
158 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79116683 |
159 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.78830669 |
160 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78797536 |
161 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78449244 |
162 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78214763 |
163 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77528444 |
164 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77469528 |
165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76713070 |
166 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76207110 |
167 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.76172593 |
168 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.75351518 |
169 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.75113241 |
170 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.74620577 |
171 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74321599 |
172 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73976716 |
173 | AR_20517297_ChIP-Seq_VCAP_Human | 0.73417832 |
174 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.72700490 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002877_abnormal_melanocyte_morpholog | 6.07113660 |
2 | MP0003283_abnormal_digestive_organ | 5.82599672 |
3 | MP0009780_abnormal_chondrocyte_physiolo | 4.55800076 |
4 | * MP0002693_abnormal_pancreas_physiology | 4.50077932 |
5 | MP0004043_abnormal_pH_regulation | 4.41368271 |
6 | MP0003195_calcinosis | 4.01640811 |
7 | MP0002909_abnormal_adrenal_gland | 4.00324350 |
8 | * MP0001944_abnormal_pancreas_morphology | 3.95918160 |
9 | MP0005379_endocrine/exocrine_gland_phen | 3.54583924 |
10 | MP0000678_abnormal_parathyroid_gland | 3.53595231 |
11 | MP0010386_abnormal_urinary_bladder | 3.35258390 |
12 | MP0000013_abnormal_adipose_tissue | 3.23089805 |
13 | MP0010368_abnormal_lymphatic_system | 3.08318242 |
14 | MP0005220_abnormal_exocrine_pancreas | 3.02281642 |
15 | MP0005360_urolithiasis | 2.93999497 |
16 | MP0003183_abnormal_peptide_metabolism | 2.86496622 |
17 | MP0002736_abnormal_nociception_after | 2.69697727 |
18 | MP0003724_increased_susceptibility_to | 2.69279594 |
19 | MP0005464_abnormal_platelet_physiology | 2.65370776 |
20 | MP0004885_abnormal_endolymph | 2.50664969 |
21 | * MP0002078_abnormal_glucose_homeostasis | 2.46014866 |
22 | MP0004147_increased_porphyrin_level | 2.35343823 |
23 | MP0002837_dystrophic_cardiac_calcinosis | 2.34285062 |
24 | MP0008872_abnormal_physiological_respon | 2.25050969 |
25 | MP0004264_abnormal_extraembryonic_tissu | 2.21947857 |
26 | MP0000462_abnormal_digestive_system | 2.11378939 |
27 | MP0005167_abnormal_blood-brain_barrier | 2.10229779 |
28 | MP0006072_abnormal_retinal_apoptosis | 2.07154053 |
29 | MP0001879_abnormal_lymphatic_vessel | 2.02195670 |
30 | MP0008004_abnormal_stomach_pH | 1.97558480 |
31 | MP0001968_abnormal_touch/_nociception | 1.94111800 |
32 | MP0001986_abnormal_taste_sensitivity | 1.93697185 |
33 | MP0004130_abnormal_muscle_cell | 1.90355163 |
34 | MP0002928_abnormal_bile_duct | 1.86978003 |
35 | MP0005551_abnormal_eye_electrophysiolog | 1.86262537 |
36 | MP0008775_abnormal_heart_ventricle | 1.82285758 |
37 | MP0009697_abnormal_copulation | 1.82194484 |
38 | MP0002638_abnormal_pupillary_reflex | 1.80569941 |
39 | MP0003300_gastrointestinal_ulcer | 1.79738339 |
40 | MP0000003_abnormal_adipose_tissue | 1.72062645 |
41 | MP0003122_maternal_imprinting | 1.71957936 |
42 | MP0008995_early_reproductive_senescence | 1.70047630 |
43 | MP0002234_abnormal_pharynx_morphology | 1.68731191 |
44 | MP0005503_abnormal_tendon_morphology | 1.63840632 |
45 | MP0005595_abnormal_vascular_smooth | 1.63341174 |
46 | MP0002896_abnormal_bone_mineralization | 1.58143548 |
47 | MP0003950_abnormal_plasma_membrane | 1.57323216 |
48 | MP0001765_abnormal_ion_homeostasis | 1.57309265 |
49 | MP0004084_abnormal_cardiac_muscle | 1.56774747 |
50 | MP0003953_abnormal_hormone_level | 1.55864990 |
51 | MP0006276_abnormal_autonomic_nervous | 1.55127700 |
52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54845260 |
53 | MP0000613_abnormal_salivary_gland | 1.52128751 |
54 | MP0004215_abnormal_myocardial_fiber | 1.51834985 |
55 | MP0005085_abnormal_gallbladder_physiolo | 1.45960999 |
56 | MP0002295_abnormal_pulmonary_circulatio | 1.45330287 |
57 | MP0003868_abnormal_feces_composition | 1.42426685 |
58 | MP0002735_abnormal_chemical_nociception | 1.41639583 |
59 | MP0005083_abnormal_biliary_tract | 1.40317562 |
60 | MP0005257_abnormal_intraocular_pressure | 1.37375967 |
61 | MP0000465_gastrointestinal_hemorrhage | 1.36509604 |
62 | MP0008961_abnormal_basal_metabolism | 1.33928507 |
63 | MP0003172_abnormal_lysosome_physiology | 1.33726565 |
64 | MP0005645_abnormal_hypothalamus_physiol | 1.33555770 |
65 | MP0009643_abnormal_urine_homeostasis | 1.32485423 |
66 | MP0004272_abnormal_basement_membrane | 1.30122281 |
67 | MP0003787_abnormal_imprinting | 1.29004811 |
68 | MP0003705_abnormal_hypodermis_morpholog | 1.27358957 |
69 | MP0002163_abnormal_gland_morphology | 1.27272436 |
70 | MP0005310_abnormal_salivary_gland | 1.26764460 |
71 | MP0005332_abnormal_amino_acid | 1.25454105 |
72 | MP0010329_abnormal_lipoprotein_level | 1.21217926 |
73 | MP0001501_abnormal_sleep_pattern | 1.20109486 |
74 | MP0003252_abnormal_bile_duct | 1.16747816 |
75 | MP0003186_abnormal_redox_activity | 1.16087786 |
76 | MP0005535_abnormal_body_temperature | 1.14759416 |
77 | MP0001270_distended_abdomen | 1.14400530 |
78 | MP0003119_abnormal_digestive_system | 1.13165342 |
79 | MP0000249_abnormal_blood_vessel | 1.07803277 |
80 | MP0005410_abnormal_fertilization | 1.05962734 |
81 | MP0002132_abnormal_respiratory_system | 1.05303734 |
82 | MP0002733_abnormal_thermal_nociception | 1.05222872 |
83 | MP0006054_spinal_hemorrhage | 1.05184117 |
84 | MP0004484_altered_response_of | 1.04928460 |
85 | MP0003890_abnormal_embryonic-extraembry | 1.04020516 |
86 | MP0005365_abnormal_bile_salt | 1.03954374 |
87 | MP0000639_abnormal_adrenal_gland | 1.01290282 |
88 | MP0004270_analgesia | 1.01173209 |
89 | MP0002160_abnormal_reproductive_system | 1.00737212 |
90 | MP0003866_abnormal_defecation | 1.00051558 |
91 | MP0002876_abnormal_thyroid_physiology | 1.00002636 |
92 | MP0005367_renal/urinary_system_phenotyp | 0.99662243 |
93 | MP0000516_abnormal_urinary_system | 0.99662243 |
94 | MP0005448_abnormal_energy_balance | 0.98200182 |
95 | MP0005647_abnormal_sex_gland | 0.98063032 |
96 | MP0005165_increased_susceptibility_to | 0.96645180 |
97 | MP0005058_abnormal_lysosome_morphology | 0.96308348 |
98 | MP0003959_abnormal_lean_body | 0.95388513 |
99 | MP0005636_abnormal_mineral_homeostasis | 0.94449922 |
100 | MP0003638_abnormal_response/metabolism_ | 0.94098522 |
101 | MP0001756_abnormal_urination | 0.93542991 |
102 | MP0005187_abnormal_penis_morphology | 0.92327913 |
103 | MP0002138_abnormal_hepatobiliary_system | 0.91652744 |
104 | MP0001764_abnormal_homeostasis | 0.91383330 |
105 | MP0004085_abnormal_heartbeat | 0.90564797 |
106 | MP0001502_abnormal_circadian_rhythm | 0.88950888 |
107 | MP0003045_fibrosis | 0.88040950 |
108 | MP0009115_abnormal_fat_cell | 0.88035032 |
109 | MP0009672_abnormal_birth_weight | 0.87175056 |
110 | MP0003279_aneurysm | 0.86981293 |
111 | MP0005408_hypopigmentation | 0.86444889 |
112 | MP0002971_abnormal_brown_adipose | 0.86371484 |
113 | MP0001661_extended_life_span | 0.85048888 |
114 | MP0005084_abnormal_gallbladder_morpholo | 0.84389624 |
115 | MP0002108_abnormal_muscle_morphology | 0.84335266 |
116 | MP0005164_abnormal_response_to | 0.81941247 |
117 | MP0000230_abnormal_systemic_arterial | 0.81395442 |
118 | MP0002139_abnormal_hepatobiliary_system | 0.80317078 |
119 | MP0000681_abnormal_thyroid_gland | 0.79623471 |
120 | MP0000383_abnormal_hair_follicle | 0.78633876 |
121 | MP0000427_abnormal_hair_cycle | 0.78051741 |
122 | MP0005395_other_phenotype | 0.77968546 |
123 | MP0006292_abnormal_olfactory_placode | 0.72927787 |
124 | MP0009764_decreased_sensitivity_to | 0.72754970 |
125 | MP0000647_abnormal_sebaceous_gland | 0.72687257 |
126 | * MP0000631_abnormal_neuroendocrine_gland | 0.72517564 |
127 | MP0005253_abnormal_eye_physiology | 0.72131084 |
128 | MP0005275_abnormal_skin_tensile | 0.72105148 |
129 | MP0003879_abnormal_hair_cell | 0.71737022 |
130 | MP0002102_abnormal_ear_morphology | 0.70770930 |
131 | MP0005375_adipose_tissue_phenotype | 0.70171688 |
132 | MP0001970_abnormal_pain_threshold | 0.69327920 |
133 | MP0003718_maternal_effect | 0.69065543 |
134 | MP0001666_abnormal_nutrient_absorption | 0.68946616 |
135 | MP0001299_abnormal_eye_distance/ | 0.68638012 |
136 | MP0002127_abnormal_cardiovascular_syste | 0.68290377 |
137 | MP0003123_paternal_imprinting | 0.68250339 |
138 | MP0001486_abnormal_startle_reflex | 0.68235996 |
139 | MP0006138_congestive_heart_failure | 0.68207662 |
140 | MP0005334_abnormal_fat_pad | 0.67038423 |
141 | MP0002115_abnormal_skeleton_extremities | 0.65951499 |
142 | MP0000538_abnormal_urinary_bladder | 0.63402791 |
143 | MP0009703_decreased_birth_body | 0.63103475 |
144 | MP0002118_abnormal_lipid_homeostasis | 0.62796221 |
145 | MP0008877_abnormal_DNA_methylation | 0.61563529 |
146 | MP0005670_abnormal_white_adipose | 0.61319093 |
147 | MP0002168_other_aberrant_phenotype | 0.61285456 |
148 | MP0004145_abnormal_muscle_electrophysio | 0.60847664 |
149 | MP0001919_abnormal_reproductive_system | 0.60707993 |
150 | MP0003795_abnormal_bone_structure | 0.60435107 |
151 | MP0003121_genomic_imprinting | 0.58798555 |
152 | * MP0009642_abnormal_blood_homeostasis | 0.56653757 |
153 | MP0005452_abnormal_adipose_tissue | 0.55198295 |
154 | MP0005076_abnormal_cell_differentiation | 0.54701867 |
155 | MP0002177_abnormal_outer_ear | 0.52717085 |
156 | MP0002653_abnormal_ependyma_morphology | 0.51924161 |
157 | MP0002970_abnormal_white_adipose | 0.51617587 |
158 | MP0005389_reproductive_system_phenotype | 0.49936075 |
159 | MP0001664_abnormal_digestion | 0.49515798 |
160 | MP0000163_abnormal_cartilage_morphology | 0.48654222 |
161 | MP0002069_abnormal_eating/drinking_beha | 0.48074409 |
162 | MP0004036_abnormal_muscle_relaxation | 0.47442451 |
163 | MP0005248_abnormal_Harderian_gland | 0.46193375 |
164 | MP0001731_abnormal_postnatal_growth | 0.45850449 |
165 | MP0000470_abnormal_stomach_morphology | 0.44466103 |
166 | MP0001186_pigmentation_phenotype | 0.43900229 |
167 | * MP0005646_abnormal_pituitary_gland | 0.43554658 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 9.01658880 |
2 | Hypoglycemic seizures (HP:0002173) | 8.37992455 |
3 | Symptomatic seizures (HP:0011145) | 7.55834224 |
4 | Hypoglycemic coma (HP:0001325) | 7.21345864 |
5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.97789113 |
6 | Abnormality of alanine metabolism (HP:0010916) | 6.95399837 |
7 | Hyperalaninemia (HP:0003348) | 6.95399837 |
8 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 6.95399837 |
9 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.81423086 |
10 | Hyperglycemia (HP:0003074) | 5.40874607 |
11 | Congenital sensorineural hearing impairment (HP:0008527) | 5.23761437 |
12 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.97594877 |
13 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.97594877 |
14 | Spontaneous hematomas (HP:0007420) | 4.78340435 |
15 | Ketoacidosis (HP:0001993) | 4.76147006 |
16 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.68807237 |
17 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.56232202 |
18 | Constricted visual fields (HP:0001133) | 4.43474245 |
19 | Late onset (HP:0003584) | 4.35597411 |
20 | Abnormal pancreas size (HP:0012094) | 4.33835746 |
21 | Large for gestational age (HP:0001520) | 4.33724576 |
22 | Decreased circulating renin level (HP:0003351) | 4.22731019 |
23 | Generalized aminoaciduria (HP:0002909) | 4.12435442 |
24 | Prolonged bleeding time (HP:0003010) | 3.99971107 |
25 | Menorrhagia (HP:0000132) | 3.98103894 |
26 | Petechiae (HP:0000967) | 3.93419361 |
27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.91734205 |
28 | Mucopolysacchariduria (HP:0008155) | 3.91734205 |
29 | Conjunctival telangiectasia (HP:0000524) | 3.80606024 |
30 | Osteomalacia (HP:0002749) | 3.73375278 |
31 | Attenuation of retinal blood vessels (HP:0007843) | 3.72677085 |
32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.69947967 |
33 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.69947967 |
34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.69947967 |
35 | Esophageal varix (HP:0002040) | 3.66349961 |
36 | Hypokalemia (HP:0002900) | 3.58085544 |
37 | Increased mean platelet volume (HP:0011877) | 3.50768970 |
38 | Insulin resistance (HP:0000855) | 3.45820410 |
39 | Hyperlipoproteinemia (HP:0010980) | 3.39929701 |
40 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.37617089 |
41 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.29757269 |
42 | Gingival bleeding (HP:0000225) | 3.28609909 |
43 | Increased corneal curvature (HP:0100692) | 3.21441642 |
44 | Keratoconus (HP:0000563) | 3.21441642 |
45 | Dysostosis multiplex (HP:0000943) | 3.18104826 |
46 | Abnormality of the intrinsic pathway (HP:0010989) | 3.12934171 |
47 | Epistaxis (HP:0000421) | 3.07659242 |
48 | Agitation (HP:0000713) | 2.96483816 |
49 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96460978 |
50 | Thoracolumbar scoliosis (HP:0002944) | 2.92402456 |
51 | Abnormal platelet volume (HP:0011876) | 2.89798242 |
52 | Ileus (HP:0002595) | 2.88756053 |
53 | Prominent metopic ridge (HP:0005487) | 2.88479750 |
54 | White forelock (HP:0002211) | 2.87575637 |
55 | Tubulointerstitial nephritis (HP:0001970) | 2.86067339 |
56 | Portal hypertension (HP:0001409) | 2.83980352 |
57 | Abnormality of renin-angiotensin system (HP:0000847) | 2.78924234 |
58 | Hyperparathyroidism (HP:0000843) | 2.75476729 |
59 | Abnormality of the renal cortex (HP:0011035) | 2.71752341 |
60 | Ketosis (HP:0001946) | 2.69338133 |
61 | Abnormality of potassium homeostasis (HP:0011042) | 2.69106964 |
62 | Myocardial infarction (HP:0001658) | 2.68060276 |
63 | Purpura (HP:0000979) | 2.65109812 |
64 | Chronic bronchitis (HP:0004469) | 2.61055283 |
65 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.60250106 |
66 | Villous atrophy (HP:0011473) | 2.60250106 |
67 | Renal cortical cysts (HP:0000803) | 2.55789800 |
68 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.55556212 |
69 | Hypoplasia of the fovea (HP:0007750) | 2.55556212 |
70 | Abnormality of the hepatic vasculature (HP:0006707) | 2.55531228 |
71 | Limb hypertonia (HP:0002509) | 2.55127605 |
72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.54090491 |
73 | Pigmentary retinal degeneration (HP:0001146) | 2.52332653 |
74 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.50628400 |
75 | Patchy hypopigmentation of hair (HP:0011365) | 2.48176303 |
76 | Metaphyseal dysplasia (HP:0100255) | 2.48113812 |
77 | Abnormality of the metopic suture (HP:0005556) | 2.47889419 |
78 | Decreased central vision (HP:0007663) | 2.45800961 |
79 | Unilateral renal agenesis (HP:0000122) | 2.44341394 |
80 | Pancreatic cysts (HP:0001737) | 2.43004308 |
81 | Abnormality of the fovea (HP:0000493) | 2.42173059 |
82 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.38702858 |
83 | Single umbilical artery (HP:0001195) | 2.38702858 |
84 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.38702858 |
85 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.38390971 |
86 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.38390971 |
87 | Abnormal protein glycosylation (HP:0012346) | 2.38390971 |
88 | Abnormal glycosylation (HP:0012345) | 2.38390971 |
89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38002266 |
90 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.37367620 |
91 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.37367620 |
92 | Nausea (HP:0002018) | 2.36855907 |
93 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.36729609 |
94 | Progressive neurologic deterioration (HP:0002344) | 2.35774211 |
95 | Hypsarrhythmia (HP:0002521) | 2.35710348 |
96 | Hypothermia (HP:0002045) | 2.35563366 |
97 | Chronic hepatic failure (HP:0100626) | 2.34665470 |
98 | Exocrine pancreatic insufficiency (HP:0001738) | 2.33329487 |
99 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.32918850 |
100 | Chorioretinal atrophy (HP:0000533) | 2.32669050 |
101 | Abnormality of serum amino acid levels (HP:0003112) | 2.30535320 |
102 | Retinal atrophy (HP:0001105) | 2.28954528 |
103 | Pancreatic fibrosis (HP:0100732) | 2.28306540 |
104 | Epileptiform EEG discharges (HP:0011182) | 2.27617858 |
105 | Action tremor (HP:0002345) | 2.27611899 |
106 | Abolished electroretinogram (ERG) (HP:0000550) | 2.27124574 |
107 | Abdominal distention (HP:0003270) | 2.27016603 |
108 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.23905667 |
109 | Oligomenorrhea (HP:0000876) | 2.23374758 |
110 | True hermaphroditism (HP:0010459) | 2.23213574 |
111 | Hyperphosphatemia (HP:0002905) | 2.22106774 |
112 | Hyperkalemia (HP:0002153) | 2.21361930 |
113 | Gout (HP:0001997) | 2.20160582 |
114 | Hypophosphatemia (HP:0002148) | 2.14640646 |
115 | Pheochromocytoma (HP:0002666) | 2.11756648 |
116 | Tubulointerstitial abnormality (HP:0001969) | 2.10794672 |
117 | Abnormality of midbrain morphology (HP:0002418) | 2.09649308 |
118 | Molar tooth sign on MRI (HP:0002419) | 2.09649308 |
119 | Proximal tubulopathy (HP:0000114) | 2.08798962 |
120 | Complete atrioventricular canal defect (HP:0001674) | 2.07771777 |
121 | Congenital stationary night blindness (HP:0007642) | 2.05996204 |
122 | Homocystinuria (HP:0002156) | 2.05646832 |
123 | Abnormality of homocysteine metabolism (HP:0010919) | 2.05646832 |
124 | Dysautonomia (HP:0002459) | 2.04640415 |
125 | Hyperventilation (HP:0002883) | 2.02437725 |
126 | Type I transferrin isoform profile (HP:0003642) | 2.00793359 |
127 | Dyschromatopsia (HP:0007641) | 1.99262173 |
128 | Papilledema (HP:0001085) | 1.99119692 |
129 | Menstrual irregularities (HP:0000858) | 1.98131760 |
130 | Hyperphosphaturia (HP:0003109) | 1.97655969 |
131 | Irregular vertebral endplates (HP:0003301) | 1.97102064 |
132 | Visual hallucinations (HP:0002367) | 1.93776627 |
133 | Hypercortisolism (HP:0001578) | 1.93757806 |
134 | Abnormality of the renal collecting system (HP:0004742) | 1.92848991 |
135 | Cortical visual impairment (HP:0100704) | 1.92305530 |
136 | Intestinal atresia (HP:0011100) | 1.91741344 |
137 | Abnormality of purine metabolism (HP:0004352) | 1.91611589 |
138 | Abnormal platelet function (HP:0011869) | 1.90108132 |
139 | Impaired platelet aggregation (HP:0003540) | 1.90108132 |
140 | Protuberant abdomen (HP:0001538) | 1.89375529 |
141 | Aortic aneurysm (HP:0004942) | 1.88976094 |
142 | Short tibia (HP:0005736) | 1.88481023 |
143 | Hypophosphatemic rickets (HP:0004912) | 1.88116197 |
144 | Abnormality of the renal medulla (HP:0100957) | 1.88011702 |
145 | Elevated alkaline phosphatase (HP:0003155) | 1.87021642 |
146 | Poor speech (HP:0002465) | 1.86446752 |
147 | Poikilocytosis (HP:0004447) | 1.85401269 |
148 | Cone-rod dystrophy (HP:0000548) | 1.85367950 |
149 | Congenital glaucoma (HP:0001087) | 1.84909851 |
150 | Increased circulating renin level (HP:0000848) | 1.84402504 |
151 | Bruising susceptibility (HP:0000978) | 1.84370546 |
152 | Chronic otitis media (HP:0000389) | 1.84128762 |
153 | Hypokalemic alkalosis (HP:0001949) | 1.83902190 |
154 | Missing ribs (HP:0000921) | 1.82123220 |
155 | Abnormal biliary tract morphology (HP:0012440) | 1.81469478 |
156 | Restlessness (HP:0000711) | 1.80193345 |
157 | Acute hepatic failure (HP:0006554) | 1.79300629 |
158 | Duplicated collecting system (HP:0000081) | 1.78984949 |
159 | Anorexia (HP:0002039) | 1.78430196 |
160 | Papillary thyroid carcinoma (HP:0002895) | 1.77320113 |
161 | Disproportionate short-trunk short stature (HP:0003521) | 1.77254330 |
162 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77089779 |
163 | Thyroid-stimulating hormone excess (HP:0002925) | 1.76804498 |
164 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76211834 |
165 | Toxemia of pregnancy (HP:0100603) | 1.76205866 |
166 | Pulmonary embolism (HP:0002204) | 1.75659497 |
167 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75164831 |
168 | Hypotension (HP:0002615) | 1.74991058 |
169 | Hypoalphalipoproteinemia (HP:0003233) | 1.73863589 |
170 | Neuroendocrine neoplasm (HP:0100634) | 1.72463446 |
171 | Hypomagnesemia (HP:0002917) | 1.71462751 |
172 | Nephronophthisis (HP:0000090) | 1.70922017 |
173 | Adrenal overactivity (HP:0002717) | 1.69811437 |
174 | Cystic liver disease (HP:0006706) | 1.69805372 |
175 | Primary adrenal insufficiency (HP:0008207) | 1.69766086 |
176 | Abnormal drinking behavior (HP:0030082) | 1.69229334 |
177 | Polydipsia (HP:0001959) | 1.69229334 |
178 | Stage 5 chronic kidney disease (HP:0003774) | 1.69141799 |
179 | Heterochromia iridis (HP:0001100) | 1.69087571 |
180 | Decreased subcutaneous fat (HP:0001002) | 1.67521659 |
181 | Metabolic alkalosis (HP:0200114) | 1.67222795 |
182 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.66740766 |
183 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.66476927 |
184 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.66476927 |
185 | Abnormality of glycolipid metabolism (HP:0010969) | 1.66476927 |
186 | Abnormality of chloride homeostasis (HP:0011422) | 1.65961098 |
187 | Glycosuria (HP:0003076) | 1.65355477 |
188 | Abnormality of urine glucose concentration (HP:0011016) | 1.65355477 |
189 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.65229545 |
190 | Spontaneous abortion (HP:0005268) | 1.61904804 |
191 | Hyperaldosteronism (HP:0000859) | 1.60635296 |
192 | Visceral angiomatosis (HP:0100761) | 1.60524873 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 8.27116831 |
2 | PASK | 6.83832094 |
3 | MAPK15 | 4.41400741 |
4 | TAOK3 | 3.67793505 |
5 | PRKD3 | 3.55537557 |
6 | ACVR1B | 3.40321348 |
7 | HIPK2 | 3.38399709 |
8 | TIE1 | 2.91446987 |
9 | FLT3 | 2.74150604 |
10 | MYLK | 2.71706931 |
11 | MAP3K2 | 2.52530430 |
12 | ERN1 | 2.44271166 |
13 | BMPR1B | 2.43846914 |
14 | ADRBK2 | 2.04610127 |
15 | FRK | 2.02215406 |
16 | MST4 | 2.01384531 |
17 | NTRK1 | 1.89023253 |
18 | EPHA3 | 1.85199371 |
19 | GRK1 | 1.76297270 |
20 | PTK2B | 1.72184486 |
21 | MAP2K3 | 1.72168624 |
22 | ADRBK1 | 1.70366078 |
23 | LMTK2 | 1.66716669 |
24 | MAP3K1 | 1.65414987 |
25 | SCYL2 | 1.64642071 |
26 | PDGFRA | 1.62200944 |
27 | NTRK3 | 1.57260791 |
28 | CDK9 | 1.54823080 |
29 | BRSK2 | 1.51067053 |
30 | STK39 | 1.41850757 |
31 | PIK3CA | 1.40786808 |
32 | TRPM7 | 1.39697258 |
33 | CAMKK2 | 1.39019727 |
34 | MAP4K2 | 1.32071526 |
35 | WNK4 | 1.30777626 |
36 | PINK1 | 1.29928056 |
37 | PTK2 | 1.27585450 |
38 | EPHB2 | 1.27404754 |
39 | BMX | 1.20271274 |
40 | PRKD2 | 1.19315331 |
41 | PRKCH | 1.18770427 |
42 | IRAK3 | 1.17709444 |
43 | STK3 | 1.16589850 |
44 | MET | 1.13439525 |
45 | IRAK1 | 1.12234287 |
46 | ZAK | 1.11571032 |
47 | CDC42BPA | 1.11064874 |
48 | PHKG2 | 1.11003623 |
49 | PHKG1 | 1.11003623 |
50 | UHMK1 | 1.10342141 |
51 | EIF2AK3 | 1.10064598 |
52 | DYRK1B | 1.00140906 |
53 | PTK6 | 0.96284306 |
54 | OXSR1 | 0.94509966 |
55 | PAK3 | 0.93128443 |
56 | LATS1 | 0.93018877 |
57 | GRK5 | 0.91892304 |
58 | EIF2AK1 | 0.90028706 |
59 | NTRK2 | 0.86482725 |
60 | BRAF | 0.85958286 |
61 | RPS6KB2 | 0.84728911 |
62 | TLK1 | 0.84236157 |
63 | FGR | 0.82984017 |
64 | DAPK2 | 0.81997703 |
65 | SGK3 | 0.80299164 |
66 | PRKG2 | 0.80288402 |
67 | NLK | 0.78523996 |
68 | BCKDK | 0.77959237 |
69 | TRIB3 | 0.75456453 |
70 | JAK3 | 0.75304979 |
71 | MAP2K2 | 0.75285866 |
72 | SIK1 | 0.72792012 |
73 | RET | 0.72690891 |
74 | BRSK1 | 0.71506948 |
75 | WNK3 | 0.68882889 |
76 | AKT3 | 0.67576547 |
77 | JAK2 | 0.67440885 |
78 | CAMK1 | 0.67317540 |
79 | ITK | 0.65084838 |
80 | PRKCE | 0.64946137 |
81 | KDR | 0.64727256 |
82 | PNCK | 0.63697715 |
83 | ERBB3 | 0.63518445 |
84 | TGFBR1 | 0.63021835 |
85 | TNIK | 0.62030066 |
86 | FGFR4 | 0.57894037 |
87 | PRKAA1 | 0.57819010 |
88 | KIT | 0.56359745 |
89 | PLK2 | 0.55018273 |
90 | FER | 0.54996072 |
91 | ROCK1 | 0.53519207 |
92 | PKN1 | 0.52599123 |
93 | CDK8 | 0.52198528 |
94 | IKBKB | 0.49847588 |
95 | PRKCI | 0.48974322 |
96 | CAMK2A | 0.48866127 |
97 | KSR2 | 0.48800645 |
98 | CAMK2G | 0.47574109 |
99 | CSF1R | 0.46224916 |
100 | BRD4 | 0.46208190 |
101 | MAP3K3 | 0.46058143 |
102 | ABL1 | 0.45781343 |
103 | CSNK1G1 | 0.45441767 |
104 | JAK1 | 0.44131202 |
105 | MAPKAPK5 | 0.43636410 |
106 | IRAK2 | 0.42442674 |
107 | TNK2 | 0.40144069 |
108 | SYK | 0.39870007 |
109 | MARK2 | 0.38633444 |
110 | CAMK2D | 0.37397552 |
111 | RPS6KA2 | 0.36352200 |
112 | CHUK | 0.36339834 |
113 | TEC | 0.36313416 |
114 | CASK | 0.35911752 |
115 | BMPR2 | 0.35602345 |
116 | IGF1R | 0.35566543 |
117 | EPHB1 | 0.35469326 |
118 | NEK6 | 0.33964954 |
119 | PRKG1 | 0.33958428 |
120 | AKT2 | 0.33794669 |
121 | PRKACG | 0.32378167 |
122 | PRKD1 | 0.31958887 |
123 | CCNB1 | 0.30521557 |
124 | ZAP70 | 0.30483142 |
125 | PDGFRB | 0.29364955 |
126 | CSNK1A1 | 0.29099834 |
127 | GSK3A | 0.28172904 |
128 | PRKDC | 0.28105465 |
129 | BCR | 0.28089323 |
130 | PRKACA | 0.27828224 |
131 | PIK3CG | 0.26504273 |
132 | RPS6KB1 | 0.25959723 |
133 | CAMKK1 | 0.25846481 |
134 | WNK1 | 0.25669840 |
135 | FGFR3 | 0.25534284 |
136 | MTOR | 0.25313473 |
137 | MAPK14 | 0.25311214 |
138 | MUSK | 0.23711534 |
139 | ERBB4 | 0.21279970 |
140 | MAPK13 | 0.20104820 |
141 | NUAK1 | 0.19944548 |
142 | IRAK4 | 0.19676312 |
143 | SGK2 | 0.19458525 |
144 | BTK | 0.19458507 |
145 | MAP2K1 | 0.19251663 |
146 | MAPKAPK3 | 0.19058542 |
147 | CDK5 | 0.18324319 |
148 | AKT1 | 0.17866462 |
149 | STK38L | 0.17406120 |
150 | CAMK2B | 0.15477181 |
151 | PRKCA | 0.15256940 |
152 | MAPK3 | 0.14791375 |
153 | PRKAA2 | 0.14231190 |
154 | DYRK1A | 0.13887154 |
155 | SGK494 | 0.13817501 |
156 | SGK223 | 0.13817501 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.69826194 |
2 | Protein export_Homo sapiens_hsa03060 | 5.71646410 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.57992777 |
4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.46357397 |
5 | Insulin secretion_Homo sapiens_hsa04911 | 3.12940686 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.00222151 |
7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.52005562 |
8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.25838005 |
9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.25484967 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.19301236 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.11483885 |
12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.10227087 |
13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.06739646 |
14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.88310220 |
15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84472262 |
16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.82913810 |
17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.81872704 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78493315 |
19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70819330 |
20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70210214 |
21 | Platelet activation_Homo sapiens_hsa04611 | 1.67891570 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.63430474 |
23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.63191441 |
24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60780563 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60742613 |
26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.54947964 |
27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52034881 |
28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46899194 |
29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46312055 |
30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42254247 |
31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38426544 |
32 | Lysosome_Homo sapiens_hsa04142 | 1.36832534 |
33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32086564 |
34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27689390 |
35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27375135 |
36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25836623 |
37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.20180733 |
38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18068509 |
39 | Peroxisome_Homo sapiens_hsa04146 | 1.16672956 |
40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13797289 |
41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13303786 |
42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11387133 |
43 | Salivary secretion_Homo sapiens_hsa04970 | 1.11073346 |
44 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.09194185 |
45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08625524 |
46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07818921 |
47 | Taste transduction_Homo sapiens_hsa04742 | 1.07229245 |
48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07199123 |
49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04924018 |
50 | Insulin resistance_Homo sapiens_hsa04931 | 1.04506977 |
51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04150084 |
52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03937524 |
53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03029387 |
54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01317763 |
55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00810672 |
56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00049491 |
57 | Phototransduction_Homo sapiens_hsa04744 | 0.98934478 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96897248 |
59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95487939 |
60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95069342 |
61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95010323 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94685198 |
63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93589520 |
64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92192976 |
65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89457155 |
66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89351298 |
67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86939539 |
68 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85176357 |
69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84543770 |
70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83338495 |
71 | Bile secretion_Homo sapiens_hsa04976 | 0.82100107 |
72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81917573 |
73 | ABC transporters_Homo sapiens_hsa02010 | 0.81613803 |
74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81372024 |
75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80420695 |
76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78368553 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76080965 |
78 | Mineral absorption_Homo sapiens_hsa04978 | 0.70494799 |
79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68019971 |
80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66421897 |
81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64992779 |
82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63968390 |
83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63457038 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63317725 |
85 | Prion diseases_Homo sapiens_hsa05020 | 0.63275810 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60634130 |
87 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60181302 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59865340 |
89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59601283 |
90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59372687 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58966492 |
92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57314416 |
93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57089885 |
94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56114593 |
95 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56027556 |
96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.55280464 |
97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55081607 |
98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52234457 |
99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51362543 |
100 | Long-term depression_Homo sapiens_hsa04730 | 0.50676150 |
101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50459838 |
102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49762995 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48911715 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46817391 |
105 | Alcoholism_Homo sapiens_hsa05034 | 0.44486621 |
106 | Lysine degradation_Homo sapiens_hsa00310 | 0.44445982 |
107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.44156841 |
108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42416295 |
109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41851466 |
110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41712813 |
111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39830150 |
112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39023762 |
113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38280989 |
114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37536156 |
115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35061595 |
116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.34450586 |
117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34375500 |
118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32751730 |
119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32661455 |
120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32185618 |
121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31989899 |
122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31500265 |
123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31185422 |
124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30568833 |
125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28209285 |
126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27955116 |
127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26606577 |
128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26381100 |
129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25803929 |
130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25539079 |
131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25203668 |
132 | Renin secretion_Homo sapiens_hsa04924 | 0.25181075 |
133 | Prostate cancer_Homo sapiens_hsa05215 | 0.24780215 |
134 | Morphine addiction_Homo sapiens_hsa05032 | 0.24648843 |
135 | Legionellosis_Homo sapiens_hsa05134 | 0.23407195 |
136 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23275951 |
137 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22742541 |
138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21798063 |
139 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18356698 |
140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.17425133 |
141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16638197 |
142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15391921 |
143 | Bladder cancer_Homo sapiens_hsa05219 | 0.12717240 |
144 | Phagosome_Homo sapiens_hsa04145 | 0.12658509 |
145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12548962 |
146 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.09508349 |
147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09057105 |
148 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.08640440 |
149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08172486 |
150 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.07992214 |
151 | Gap junction_Homo sapiens_hsa04540 | 0.07070784 |
152 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.06882717 |
153 | Melanogenesis_Homo sapiens_hsa04916 | 0.06576376 |
154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05834936 |